Yung-Ping Yeh - 22 Nov 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role
Chief Innovation Officer, Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
22 Nov 2021
Net transactions value
+$1,025
Form type
4
Filing time
23 Nov 2021, 18:51:43 UTC
Previous filing
27 Aug 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $1,025 +500 +4.1% $2.05 12,762 22 Nov 2021 Direct
holding VYNT Common Stock, $0.0001 par value 1,315,363 22 Nov 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.